Angioplasty Balloons Market Size, Share, Opportunities, And Trends By Type (Normal Balloons, Drug Eluting Balloons, Cutting Balloons, Scoring Balloons), By Application (Peripheral, Coronary), By End-Use (ASCs, Hospitals, Cath Labs), And By Geography - Forecasts From 2025 To 2030

The angioplasty balloons market is projected to grow at a CAGR of 4.91% over the forecast period, increasing from US$2.885 billion in 2025 to US$3.602 billion by 2030.

Balloon angioplasty is a procedure used to open narrowed or blocked arteries. It is a minimum-invasive surgery, the growth of the minimally invasive procedures drives the overall growth. The angioplasty balloons market is witnessing growth driven by increased cases of CVDs (cardiovascular diseases) by the ageing population and increased lifestyle-related risk factors.  CVDs are the leading cause of death around the world. The favourable regulatory environment is also driving the angioplasty balloons market growth. Moreover, the angioplasty balloons market is also witnessing innovative product developments and applications. For instance, according to Eurostat (25 EU countries), there were 1.06 million transluminal coronary angioplasty procedures conducted in 2022. The transluminal coronary angioplasty was a common form of intervention for patients treated for cardiovascular diseases in the region.

What are the Angioplasty Balloons Market Drivers?

• The increasing prevalence of cardiovascular diseases bolsters the angioplasty balloons market growth

Angioplasty is used during a heart attack to open a blockage and restore blood flow. Moreover, balloon angioplasty is a minimally invasive procedure that uses a balloon to treat cardiovascular diseases. Every year cardiovascular disease (CVD) engulfs over 20.5 million lives every year. Of these deaths, 85% are due to coronary heart diseases (e.g. heart attacks) and cerebrovascular diseases (e.g. strokes).

Further, the most common risk factors are smoking, diabetes, cholesterol, eating an unhealthy diet, or living with high blood pressure these are mostly prevalent in low- and middle-income countries. For instance, according to World Heart Day, around 620 million people were living with heart and circulatory diseases across the world in 2023. Each year around 60 million people across the world develop a heart or circulatory disease.

• A shift towards minimally invasive procedures is anticipated to increase the market demand

There has been an emergence in the medical world for less invasive procedures, with angioplasty emerging as one of the important modalities that fits within such a paradigm. In comparison with invasive open-heart surgery, minimally invasive procedures are said to give shorter recovery periods with less pain and fewer complications. Moreover, the intervention of angioplasty consists of threading an inflated balloon catheter through the blood vessels to reach the site of the blockage, which has made it possible for the procedure to be done under an anaesthetic.

• Rising technological advancement is also increasing the market demand

One of the major factors propelling the angioplasty balloons market is the continuous development and performance of angioplasty balloons. Drug-coated balloons, which give medication to help avoid re-constriction of arteries after angioplasty procedures, have greatly improved outcomes for such procedures. Moreover, due to the development of special balloons, such as those for hard or calcified lesions, the applicability of angioplasty has increased among patients.

The Angioplasty Balloons Market is analyzed into the following segments

• By type, non-compliant balloons are anticipated to grow during the forecast period

The Non-compliant (NC) balloons are stiff as they do not change size or shape with inflation pressure, unlike compliant balloon catheters. Their rigidity makes them ideal because they can develop high forces for effective dilation in calcified lesions and are also appropriate for very precise dilations, making them particularly well-suited for complex procedures requiring much accuracy.  NC balloons are made from robust materials that work to resist deformation and maintain radial force during dilation. They can be considered as having limited conforming devices to the vessel wall; hence, idealized for forceful dilation scenarios.

NC angioplasty balloons are specialized balloons applied in interventional cardiology procedures. Increasing elderly populations and increased risk factors such as obesity, diabetes, and hypertension have driven the rising incidence of cardiovascular disease. The ever-rising number of patients suffering from these conditions has had a corresponding effect on the rising demand for more efficient treatments like NC balloons.

• By application, the peripheral segment is anticipated to grow during the forecast period

Peripheral vascular disease, also known as peripheral artery disease (PAD), is a type of circulatory disorder mainly affecting blood supply through arteries to the leg and foot. It is primarily due to atherosclerosis by fatty plaque buildup within arteries with consequent narrowing and health complications. If not managed, it may result in immobility and dire health issues which continue to increase demand for angioplasty balloons in the coming years.

Further, the major market players are developing and in the process of assessing the angioplasty balloon dilatation catheter which significantly affects the PAD application segment in the angioplasty balloons market and will probably result in favourable treatment outcomes and the overall growth of the market. For instance, in September 2023, Kossel Medtech's Sabelly® non-compliant peripheral balloon dilatation catheter was approved by the National Medical Products Administration (NMPA) for market release.

Geographical outlook of the Angioplasty Balloons Market:

• Asia Pacific is witnessing exponential growth during the forecast period

The North American market growth is due to its advanced healthcare system, strong demand for cardiovascular operations, and increasing occurrence of coronary artery disease (CAD) and peripheral artery disease (PAD) have given the impetus for the market growth of the US.  Further, the surge in demand for angioplasty balloons can thus be traced in significant part to the growing aged population in the United States.  Age increases the chances of having cardiovascular diseases, for instance, hydercorendia or stenosis, which need angioplasty to clear the clogged arteries. As the ageing population has medical technology very specific for this treatment adds to the demand for such gadgets. Additionally, technological improvements have enabled the development of more advanced balloons and catheters with greater performance. These advancements, such as drug-coated balloons and cutting-edge materials, improved the effectiveness and safety of PTA operations, propelling market expansion.

Key launches in the Angioplasty Balloons Market:

• In September 2024, UHealth- the University of Miami Health System became the first academic medical centre in Florida to treat a patient with the AGENT DCB by which every future stent recipient patient can be prevented from a blockage in coronary arteries.
• In September 2024, Medtronic announced that DCBs have been shown to achieve better long-term vessel patency compared to uncoated balloons, significantly reducing the rate of restenosis and the need for repeat interventions in complex lesions.

Angioplasty Balloons Market Scope:

Report Metric	Details
Angioplasty Balloons Market Size in 2025	US$2.885 billion
Angioplasty Balloons Market Size in 2030	US$3.602 billion
Growth Rate	CAGR of 4.91%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Billion
Segmentation	Type Application End-User Industry Geography
Geographical Segmentation	North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in Angioplasty Balloons Market	Infinity Angioplasty Balloon Poba Medical Boston Scientific Philips Concept Medical
Customization Scope	Free report customization with purchase

 

The Angioplasty Balloons Market is analyzed into the following segments:

• By Type
  • Normal Balloons
  • Drug-Eluting Balloons
  • Scoring Balloons
  • Non-Compliant Balloons
  • Others
• By Application
  • Peripheral
  • Coronary
• By End-User Industry
  • ASCs
  • Hospitals
  • Cath Labs
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Others
  • Middle East and Africa
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Indonesia
    • Taiwan
    • Thailand
    • Others

---

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. CXO Perspective

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View 

5.  ANGIOPLASTY BALLOONS MARKET BY TYPE

5.1. Introduction

5.2. Normal Balloons

5.3. Drug-Eluting Balloons 

5.4. Scoring Balloons

5.5. Non-Compliant Balloons

5.6. Others

6. ANGIOPLASTY BALLOONS MARKET BY APPLICATION

6.1. Introduction

6.2. Peripheral

6.3. Coronary

7.  ANGIOPLASTY BALLOONS MARKET BY END-USER 

7.1. Introduction

7.2. ASCs

7.3. Hospitals

7.4. Cath Labs

8.  ANGIOPLASTY BALLOONS MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. By Type

8.2.2. By Application

8.2.3. By End-User 

8.2.4. By Country

8.2.4.1. USA

8.2.4.2. Canada

8.2.4.3. Mexico

8.3. South America

8.3.1. By Type

8.3.2. By Application

8.3.3. By End-User 

8.3.4. By Country

8.3.4.1. Brazil

8.3.4.2. Argentina

8.3.4.3. Others

8.4. Europe

8.4.1. By Type

8.4.2. By Application

8.4.3. By End-User 

8.4.4. By Country

8.4.4.1. Germany

8.4.4.2. UK

8.4.4.3. France

8.4.4.4. Spain

8.4.4.5. Others

8.5. Middle East and Africa

8.5.1. By Type

8.5.2. By Application

8.5.3. By End-User 

8.5.4. By Country

8.5.4.1. UAE

8.5.4.2. Israel

8.5.4.3. Others

8.6. Asia Pacific

8.6.1. By Type

8.6.2. By Application

8.6.3. By End-User 

8.6.4. By Country

8.6.4.1. China

8.6.4.2. Japan

8.6.4.3. South Korea

8.6.4.4. India

8.6.4.5. Indonesia

8.6.4.6. Taiwan

8.6.4.7. Thailand

8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Infinity Angioplasty Balloon

10.2. Poba Medical

10.3. Boston Scientific

10.4. Philips

10.5. Concept Medical

10.6. Lepu Medical Technology Company

10.7. Terumo Interventional Systems

10.8. B. Braun

10.9. Medtronic

10.10. Conic Vascular

10.11. Abbott Laboratories.

10.12. AngioDynamics.

10.13. Becton

10.14. Dickinson and Company.

Infinity Angioplasty Balloon

Poba Medical

Boston Scientific

Philips

Concept Medical

Lepu Medical Technology Company

Terumo Interventional Systems

B. Braun

Medtronic

Conic Vascular

Abbott Laboratories.

AngioDynamics.

Becton

Dickinson and Company.

BIOTRONIK.

Braun Melsungen AG.

Cook Medical.

Cordis